Mitochondrial amidoxime reducing Component 2 (MARC2), a newly identified molybdenum enzyme, was found to be downregulated in HCC cells and interacted with p27 to suppress HCC progression [33]. Here, MTARC2 is linked to hepatocellular carcinoma.